New virtual program aims to help refugees with brain injuries think clearer

NCT ID NCT06839079

Recruiting now Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This study tests a virtual cognitive rehabilitation program designed for refugees and asylum seekers who have had a traumatic brain injury (TBI) and struggle with thinking and memory. The program includes 8 virtual sessions led by trained bilingual staff, covering brain injury education and exercises for attention, memory, and relaxation. Researchers want to see if the program is practical, acceptable, and helpful for this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Trauma-informed, paraprofessional-delivered virtual cognitive rehabilitation program
What this could lead to: If successful, this could provide a practical, accessible way to help refugees with TBI improve their thinking and memory.
What could go wrong: This is a small, early feasibility study with only 50 participants, so results may not apply widely. The program may not show clear benefits or be difficult to complete virtually.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic Neurobehavioral Manifestations traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COGNITIVE SYMPTOMS TBI (TRAUMATIC BRAIN INJURY)

Contacts and locations

Locations

Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.